Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Useful Contacts |
  6. Site Map |
  7. Help

  1. Font size

    Reduce font size Increase font size  
 
 

Press Room

Contact us

Our Media contact is:

The Communications Manager

Sanofi
Talavera Corporate Centre
Building D
12-24 Talavera Road
Macquarie Park, NSW 2113
+61 (0)2 8666 2000

Content :

News 2012

  1. October 15, 2012

    SUPPLY STATUS: ImmuCyst ® BCG Bacillus Calmette-Guerin (BCG) 6.6 - 19.2 x 100000000 CFU powder for injection vial, AUST R 168005

  2. October 02, 2012

    Sanofi wishes to advise that supply of Surgam (tiaprofenic acid) 300mg [60] tablets has been discontinued

  3. February 21, 2012

    Important information regarding the supply of Seprafilm® Adhesion Barrier via Special Access Scheme

  4. February 01, 2012

    Doctors wishing to use Seprafilm will need to complete the SAS form

Module :

Corporate information

Corporate information